Evidence map›Paper›PMID 38869038›Full record

ArticleCancer control : journal of the Moffitt Cancer Center

Single-Cell Molecular Profiling of Head and Neck Squamous Cell Carcinoma Reveals Five Dysregulated Signaling Pathways Associated With Circulating Tumor Cells.

Andres Stucky, Chi T Viet, Bradley E Aouizerat, Yi Ye, Coleen Doan, Tarun Mundluru, Parish Sedhiazadeh, Uttam K Sinha, Xuelian Chen, Xi Zhang and 3 more

Abstract read
In one paragraph

Article in Cancer control : journal of the Moffitt Cancer Center. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Andres StuckyDepartment of Basic Sciences, School of Medicine, Loma Linda University, Loma Linda, CA, USA.
Chi T VietDepartment of Oral and Maxillofacial Surgery, School of Dentistry, Loma Linda University, Loma Linda, CA, USA.
Bradley E AouizeratDepartment of Oral and Maxillofacial Surgery, College of Dentistry, New York University, New York, NY, USA.
Yi YeDepartment of Oral and Maxillofacial Surgery, College of Dentistry, New York University, New York, NY, USA.
Coleen DoanDepartment of Oral and Maxillofacial Surgery, School of Dentistry, Loma Linda University, Loma Linda, CA, USA.
Tarun MundluruHerman Ostrow School of Dentistry, Department of Periodontics and Diagnostic Sciences, University of Southern California, Los Angeles, CA, USA.
Parish SedhiazadehHerman Ostrow School of Dentistry, Department of Periodontics and Diagnostic Sciences, University of Southern California, Los Angeles, CA, USA.
Uttam K SinhaDepartment of Otolaryngology-Head and Neck Surgery, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA.
Xuelian ChenDepartment of Basic Sciences, School of Medicine, Loma Linda University, Loma Linda, CA, USA.
Xi ZhangDepartment of Basic Sciences, School of Medicine, Loma Linda University, Loma Linda, CA, USA.
Shengwen Calvin LiNeuro-Oncology and Stem Cell Research Laboratory, Center for Neuroscience Research, CHOC Children's Research Institute, Children's Hospital of Orange County, Orange, CA, USA.ORCID 0000-0002-9699-9204
Jin CaiDepartment of Oral and Maxillofacial Surgery, Zhuhai People's Hospital, Zhuhai Clinical Medical College of Jinan University, Zhuhai, People's Republic of China.
Jiang F ZhongDepartment of Basic Sciences, School of Medicine, Loma Linda University, Loma Linda, CA, USA.

Funding

The REASON Score: An Epigenetic And Clinicopathologic Score to Predict Risk of Poor Survival in Early Stage Oral Squamous Cell Carcinoma PatientsR01DE031395 · NIDCR · LOMA LINDA UNIVERSITY · PI Chi T. Viet · 2022 to 2026
$3.7M
PROSPECT: Premalignant Oral Lesions Pathology and Epigenetic Risk Prediction ToolR01CA293995 · NCI · LOMA LINDA UNIVERSITY · PI AOUIZERAT, BRADLEY E, PEARSON, ALEXANDER THOMAS · 2024 to 2025
$1.4M
NCI NIH HHS R01 CA293995NIDCR NIH HHS R01 DE031395
6 · The paper itself

Abstract

objectivesTo determine the dysregulated signaling pathways of head and neck squamous cell carcinoma associated with circulating tumor cells (CTCs) via single-cell molecular characterization.

introductionHead and neck squamous cell carcinoma (HNSCC) has a significant global burden and is a disease with poor survival. Despite trials exploring new treatment modalities to improve disease control rates, the 5 year survival rate remains low at only 60%. Most cancer malignancies are reported to progress to a fatal phase due to the metastatic activity derived from treatment-resistant cancer cells, regarded as one of the most significant obstacles to develope effective cancer treatment options. However, the molecular profiles of cancer cells have not been thoroughly studied.

methodsHere, we examined in-situ HNSCC tumors and pairwisely followed up with the downstream circulating tumor cells (CTCs)-based on the surrogate biomarkers to detect metastasis that is established in other cancers - not yet being fully adopted in HNSCC treatment algorithms.

resultsSpecifically, we revealed metastatic HNSCC patients have complex CTCs that could be defined through gene expression and mutational gene profiling derived from completed single-cell RNASeq (scRNASeq) that served to confirm molecular pathways inherent in these CTCs. To enhance the reliability of our findings, we cross-validated those molecular profiles with results from previously published studies.

conclusionThus, we identified 5 dysregulated signaling pathways in CTCs to derive HNSCC biomarker panels for screening HNSCC in situ tumors.

Indexed as

Head and Neck NeoplasmsNeoplastic Cells, CirculatingSignal TransductionSingle-Cell AnalysisSquamous Cell Carcinoma of Head and NeckBiomarkers, TumorFemaleGene Expression ProfilingGene Expression Regulation, NeoplasticHumansMaleMiddle AgedBiomarkers, Tumorcirculating tumor cellshead and neck squamous cell carcinoma (HNSCC)molecular pathwaysingle-cell RNASeq (scRNASeq)tumor heterogeneity

Identifiers

PMID38869038
PMCPMC11179551

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.